Your browser is no longer supported. Please, upgrade your browser.
Index- P/E- EPS (ttm)-0.07 Insider Own6.00% Shs Outstand29.16M Perf Week-4.13%
Market Cap183.04M Forward P/E25.45 EPS next Y0.25 Insider Trans0.00% Shs Float12.45M Perf Month-31.88%
Income-2.10M PEG- EPS next Q-0.01 Inst Own17.70% Short Float1.36% Perf Quarter-40.94%
Sales50.30M P/S3.64 EPS this Y-214.50% Inst Trans-3.83% Short Ratio0.55 Perf Half Y43.89%
Book/sh1.09 P/B5.74 EPS next Y125.69% ROA- Target Price- Perf Year189.15%
Cash/sh1.02 P/C6.14 EPS next 5Y3.00% ROE-6.60% 52W Range2.00 - 10.68 Perf YTD21.08%
Dividend- P/FCF- EPS past 5Y2.60% ROI-0.70% 52W High-44.88% Beta1.74
Dividend %- Quick Ratio1.70 Sales past 5Y5.30% Gross Margin44.10% 52W Low194.32% ATR0.52
Employees223 Current Ratio2.10 Sales Q/Q28.30% Oper. Margin0.70% RSI (14)25.24 Volatility7.39% 6.61%
OptionableYes Debt/Eq0.35 EPS Q/Q179.50% Profit Margin-4.10% Rel Volume2.17 Prev Close6.26
ShortableYes LT Debt/Eq0.06 EarningsMay 11 AMC Payout- Avg Volume305.70K Price5.89
Recom2.00 SMA20-20.42% SMA50-26.60% SMA200-0.51% Volume278,971 Change-5.97%
Apr-28-21Initiated Piper Sandler Overweight $13
Apr-15-20Initiated B. Riley FBR Buy $5.50
Jul-28-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
Jun-16-14Initiated H.C. Wainwright Buy $6
Mar-05-13Initiated Northland Capital Outperform $6
Nov-18-10Reiterated Morgan Joseph Buy $3 → $5.25
Aug-20-09Reiterated Roth Capital Hold $2.50 → $5
Nov-24-08Reiterated Roth Capital Hold $2.50
Mar-26-08Reiterated Roth Capital Hold $6 → $4.50
Nov-09-07Reiterated Roth Capital Hold $7 → $6
Mar-16-07Reiterated Roth Capital Hold $8.50 → $7
Jan-24-07Reiterated Roth Capital Hold $6.50 → $8.50
May-13-21 01:43AM  
May-12-21 06:45AM  
May-11-21 04:30PM  
May-04-21 08:00AM  
Apr-23-21 06:43AM  
Apr-22-21 04:01PM  
Apr-03-21 04:19AM  
Mar-31-21 06:30AM  
Mar-30-21 04:35PM  
Mar-29-21 10:05AM  
Mar-23-21 08:00AM  
Mar-03-21 08:00AM  
Jan-24-21 01:59AM  
Jan-20-21 08:00AM  
Jan-19-21 08:00AM  
Jan-14-21 08:00AM  
Jan-11-21 08:32AM  
Jan-06-21 08:00AM  
Jan-05-21 08:00AM  
Dec-30-20 08:00AM  
Dec-09-20 08:00AM  
Nov-27-20 10:08AM  
Nov-19-20 06:45AM  
Nov-18-20 05:00PM  
Nov-17-20 10:12AM  
Nov-10-20 08:46AM  
Nov-09-20 08:50AM  
Sep-29-20 08:33AM  
Sep-15-20 08:00AM  
Sep-10-20 07:22AM  
Sep-09-20 08:00AM  
Sep-03-20 08:00AM  
Aug-26-20 04:35PM  
Aug-25-20 08:00AM  
Aug-19-20 08:00AM  
Aug-18-20 08:00AM  
Aug-03-20 12:17PM  
Jul-20-20 09:19AM  
Jul-15-20 08:06AM  
Jul-07-20 11:02PM  
Jun-30-20 04:41PM  
May-28-20 08:35AM  
May-27-20 01:36PM  
May-13-20 04:35PM  
May-12-20 04:35PM  
May-06-20 08:30AM  
May-04-20 08:22AM  
Apr-04-20 08:50AM  
Mar-31-20 06:30AM  
Mar-30-20 04:35PM  
Mar-24-20 08:35AM  
Mar-17-20 08:35AM  
Feb-18-20 08:25AM  
Jan-29-20 08:30AM  
Jan-09-20 08:30AM  
Dec-31-19 11:46AM  
Dec-20-19 10:45AM  
Dec-19-19 08:30AM  
Nov-26-19 08:29AM  
Nov-18-19 09:00AM  
Nov-14-19 06:01AM  
Nov-13-19 04:32PM  
Oct-30-19 08:00AM  
Oct-24-19 08:00AM  
Sep-30-19 07:33AM  
Sep-26-19 08:31AM  
Sep-20-19 10:40AM  
Sep-06-19 10:07AM  
Aug-30-19 07:39AM  
Aug-29-19 07:38AM  
Aug-28-19 04:44PM  
Jul-26-19 12:31PM  
Jul-25-19 08:00AM  
Jun-10-19 08:30AM  
May-15-19 04:35PM  
May-14-19 05:14PM  
May-02-19 08:00AM  
Apr-29-19 08:01AM  
Apr-26-19 02:49PM  
Apr-10-19 08:39AM  
Apr-02-19 05:50PM  
Apr-01-19 04:35PM  
Mar-21-19 04:35PM  
Mar-04-19 08:01AM  
Feb-05-19 08:00AM  
Jan-22-19 11:59AM  
Jan-18-19 08:01AM  
Jan-14-19 08:00AM  
Jan-03-19 08:00AM  
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.